<DOC>
	<DOCNO>NCT01206101</DOCNO>
	<brief_summary>This trial conduct Europe North America . The aim trial investigate liraglutide treatment increase proportion insulin-independent subject one year islet cell transplantation require one ( single-donor ) islet cell transplant .</brief_summary>
	<brief_title>Efficacy Safety Liraglutide Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 1 diabetes mellitus least 5 year Candidate islet cell transplantation base upon local accepted practice guideline Reduced awareness hypoglycaemia Treatment antidiabetic medication insulin include insulin pump within 4 week trial start Any previous organ transplantation A history acute idiopathic chronic pancreatitis Family personal history multiple endocrine neoplasia type 2 ( MEN2 ) familial medullary thyroid carcinoma ( FMTC )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>